Replies to post #99646 on Anavex Life Sciences Corp (AVXL)

[seventhwave]

Also, even though the P2a trial size is very small, not blinded & with no control, Anavex may have a better shot at making a case for a single confirmatory P3 by demonstrating sustained safety AND efficacy in a patient subgroup over 1&1/2 years.